CFTR and autoimmune disease: Decreased CFTR expression has also been observed in several mouse models of autoimmune disease that respond to pharmacological treatment with CFTR potentiators, suggesting that defective CFTR function (and presumably its downstream consequence, autophagy inhibition) might play a rather general role in the pathophysiology of distinct disease entities [34,35].